Company / Operating Margin
Yubo International Biotech Ltd Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-9614.6%
FY2025
5-year range
-51006.3% / -197.6%
FY2022-FY2025
Trend
+81.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -197.6% to -9614.6% over the past 2 years.
Based on SEC 10-K filings.
-9614.6% in FY2025 with a 3-year CAGR of -8458.9%.
Declined from -197.6% to -9614.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -8458.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 81.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9614.6% | +81.2% |
| FY2024 | -51006.3% | -25715.5% |
| FY2023 | -197.6% | +82.9% |
| FY2022 | -1155.7% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026